AVLN Avalyn Pharma Inc.
Price Chart
Executive Summary
Novo Holdings A/S filed a Form 3 initial statement of beneficial ownership, disclosing ownership of convertible preferred shares in Avalyn Pharma Inc. (AVLN). The filing indicates Novo Holdings holds convertible preferred stock (Series A, B, C-1, C-2, D) that converts into 935,466 + 103,232 + 1,345,997 + 290,390 + 652,649 = 3,327,734 shares of voting common stock on a 1-for-19.2417 basis, with automatic conversion upon IPO. This is a routine insider ownership disclosure with no immediate trading implications.
Actionable Insight
This is a routine insider ownership filing with no trading activity. Monitor for any subsequent Form 4 filings that would indicate actual share transactions by Novo Holdings. The IPO conversion trigger is a key catalyst to watch.
Key Facts
- Novo Holdings A/S filed Form 3 as an initial beneficial ownership report for Avalyn Pharma Inc.
- Novo Holdings holds convertible preferred stock: Series A (935,466 common), Series B (103,232 common), Series C-1 (1,345,997 common), Series C-2 (290,390 common), Series D (652,649 common).
- Total common shares upon conversion: 3,327,734 shares.
- Conversion ratio is 1 preferred share to 19.2417 common shares, with automatic conversion upon IPO.
- Filing date: April 29, 2026.
Financial Impact
No financial figures disclosed beyond share counts. No dollar amounts reported.
Risk Factors
- No immediate market risk from this filing; it is purely informational.
- Future insider selling by Novo Holdings post-IPO could pressure the stock.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001388325-26-000017 |
| Document: 0001388325-26-000017-index.html | 0001388325-26-000017 |
| Document: 0001388325-26-000017.txt | 0001388325-26-000017 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
11d ago
|
8-K
| $26.40 $26.99 | ▲ +2.23% | ▲ +1.84% | $30.08 (+13.94%) |
|
May 5, 2026
5w ago
|
Press Release
| $27.71 $27.71 | · 0.00% | ▲ +0.33% | $30.08 (+8.55%) |
|
May 1, 2026
6w ago
|
Insider Cluster
| $29.84 $29.07 | ▼ −2.58% | ▼ −2.24% | $30.08 (+0.80%) |
|
May 1, 2026
6w ago
|
Insider Cluster
| $29.84 $29.07 | ▼ −2.58% | ▼ −2.24% | $30.08 (+0.80%) |
|
Apr 30, 2026
6w ago
|
424B4
| $29.84 $29.07 | ▼ −2.58% | ▼ −2.24% | $30.08 (+0.80%) |
|
Apr 30, 2026
6w ago
|
Press Release
| $29.49 $29.84 | ▲ +1.19% | ▲ +0.97% | $30.08 (+2.00%) |
|
Apr 30, 2026
6w ago
|
3
| $29.49 $29.84 | ▲ +1.19% | ▲ +0.97% | $30.08 (+2.00%) |
|
Apr 30, 2026
6w ago
|
3
| $29.49 $29.84 | ▲ +1.19% | ▲ +0.97% | $30.08 (+2.00%) |
|
Apr 29, 2026
6w ago
|
3
| $29.49 $29.84 | ▲ +1.19% | ▲ +0.97% | $30.08 (+2.00%) |
|
Apr 29, 2026
6w ago
|
S-1/A
| — | awaiting T+1 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access